GGrantIndex
Sort

35,931 grants matching parkinsons

NIEHS Cryo-EM Core Facility

$2,781,802
Mario Borgnia · National Institute Of Environmental Health Sciences · ZIC · FY2023 · ES

"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"

$2,776,459
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2020 · HG

Genetic and clinical studies of Gaucher disease and other lysosomal disorders

$2,768,333
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2024 · HG

Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration

$2,765,624
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2024 · DA

Functional and Pharmacological Significance of Receptor Heteromers in the CNS

$2,765,439
Sergi Ferre · National Institute On Drug Abuse · ZIA · FY2022 · DA

Basal Ganglia in Health and Disease

$2,763,395
Guohong Cui · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES

Effects-Related Biomarkers of Toxic Exposures

$2,743,925
Harvey Checkoway · University Of Washington · P42 · FY2006 · ES

Modulation Of Neuronal Channels and Receptors in the Brain

$2,741,932
Jerrel L Yakel · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES

Molecular mechanisms and cellular implications of tau dysfunction

$2,739,985
Elizabeth Rhoades · University Of Pennsylvania · RF1 · FY2016 · AG

RECRUITMENT AND SAMPLE COLLECTION FOR ANTECEDENT BIOMARKER DISCOVERY IN PARKINSON'S DISEASE

$2,737,992
Georgetown University · · FY2009 · Department of Defense

Effects-Related Biomarkers of Toxic Exposures

$2,735,488
Harvey Checkoway · University Of Washington · P42 · FY2008 · ES

Clinical Coordination Center for STEADY-PD3

$2,730,128
Tanya Simuni Simuni · Northwestern University At Chicago · U01 · FY2014 · NS

The Molecular Biology Of The Mammalian Brain

$2,719,917
Ronald McKay · National Institute Of Neurological Disorders And Stroke · ZIA · FY2010 · NS

Comprehensive Structural and Functional Mapping of Mammalian Colonic Nervous System

$2,717,567
Yvette France Tache · University Of California Los Angeles · OT2 · FY2020 · OD

Genetic and clinical studies of Gaucher disease and other lysosomal disorders

$2,714,052
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2023 · HG

"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"

$2,713,985
Ellen Sidransky · Human Genome Research · Z01 · FY2007 · HG

A Dose Selection Trial of Light Therapy for Impaired Sleep in Parkinson's Disease

$2,712,004
Aleksandar Videnovic · Massachusetts General Hospital · U01 · FY2019 · NS

Ultra-High Resolution Mass Spectrometer for Biomedical Research

$2,709,858
Joseph A Loo · University Of California Los Angeles · S10 · FY2010 · RR

"Genetic and clinical studies of Gaucher disease and other lysosomal disorders"

$2,706,100
Ellen Sidransky · National Human Genome Research Institute · ZIA · FY2019 · HG

Studies of Occupational Cancer (Pesticides)

$2,690,047
Michael Alavanja · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA

Soluble αSyn is a modulator of AD pathophysiology

$2,689,594
Sylvain E. Lesne · University Of Minnesota · RF1 · FY2019 · AG

SENSORY DYSFUNCTION IN EARLY PARKINSON'S DISEASE

$2,689,468
Trustees Of The University Of Pennsylvania, The · · FY2010 · Department of Defense

GENERAL CLINICAL RESEARCH CENTER

$2,688,678
Yale University · M01 · FY2000 · RR

Cellular mechanisms of neuronal dysfunction in addiction and neurodegeneration

$2,685,245
Brandon Harvey · National Institute On Drug Abuse · ZIA · FY2025 · DA

Effects-Related Biomarkers of Toxic Exposures

$2,680,043
Harvey Checkoway · University Of Washington · P42 · FY2007 · ES